TYENNE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 65219-590
  • Package NDC 65219-590-04
  • Application number BLA761275
  • SPL ID 363d125e-6d69-4bb2-ae09-5eeb5d9edbae
  • SPL set ID e400bbe6-43c5-4de6-82b9-cb44ce3cd906
  • UNII I031V2H011
  • RxCUI 2679431
  • RxCUI 2679438
  • RxCUI 2679440
  • RxCUI 2679441
  • RxCUI 2679442
  • RxCUI 2679443

What the source publishes

Labeler
Fresenius Kabi USA, LLC
Active ingredients
Tocilizumab-aazg
Form
INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:65219-590_363d125e-6d69-4bb2-ae09-5eeb5d9edbae
{
  "name": "TYENNE",
  "splId": "363d125e-6d69-4bb2-ae09-5eeb5d9edbae",
  "labels": [
    {
      "setId": "e400bbe6-43c5-4de6-82b9-cb44ce3cd906",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e400bbe6-43c5-4de6-82b9-cb44ce3cd906",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e400bbe6-43c5-4de6-82b9-cb44ce3cd906"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Fresenius Kabi USA, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (65219-590-04)  / 4 mL in 1 VIAL, SINGLE-DOSE",
      "package_ndc": "65219-590-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240415"
    }
  ],
  "productId": "65219-590_363d125e-6d69-4bb2-ae09-5eeb5d9edbae",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION, CONCENTRATE",
  "productNdc": "65219-590",
  "deaSchedule": null,
  "genericName": "Tocilizumab-aazg",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOCILIZUMAB",
      "strength": "80 mg/4mL"
    }
  ],
  "applicationNumber": "BLA761275",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240415",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000190478",
      "N0000190480"
    ],
    "unii": [
      "I031V2H011"
    ],
    "rxcui": [
      "2679431",
      "2679438",
      "2679440",
      "2679441",
      "2679442",
      "2679443"
    ],
    "spl_set_id": [
      "e400bbe6-43c5-4de6-82b9-cb44ce3cd906"
    ],
    "pharm_class_epc": [
      "Interleukin-6 Receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Interleukin 6 Receptor Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Fresenius Kabi USA, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:65219-590_363d125e-6d69-4bb2-ae09-5eeb5d9edbae"